No Cover Image

Journal article 440 views 108 downloads

Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial

Stephen C. Bain, Ofri Mosenzon, Rosario Arechavaleta, Pawel Bogdański, Abdurrahman Comlekci, Agostino Consoli, Chaicharn Deerochanawong, Kathleen Dungan, Maria C. Faingold, Michael E. Farkouh, Denise R. Franco, Jeppe Gram, Cristian Guja, Pankaj Joshi, Rachid Malek, Juan F. Merino-Torres, Michael A. Nauck, Sue D. Pedersen, Wayne H. -H. Sheu, Robert J. Silver, Cees J. Tack, Nikhil Tandon, Ole K. Jeppesen, Mette Strange, Mette Thomsen, Mansoor Husain, Steve Bain Orcid Logo

Diabetes, Obesity and Metabolism

Swansea University Author: Steve Bain Orcid Logo

  • 44806.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC-ND).

    Download (856.24KB)

Check full text

DOI (Published version): 10.1111/dom.13553

Published in: Diabetes, Obesity and Metabolism
ISSN: 14628902
Published: 2018
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa44806
Tags: Add Tag
No Tags, Be the first to tag this record!
College: Swansea University Medical School